HemoSonics registered its new QStat Cartridge, an extension of its Quantra Hemostasis System, for CE Mark making it available in Europe and Hong Kong for use in trauma surgery and liver transplant procedures, according to a press release.
“Trauma and liver surgeries pose an enormous risk of acute bleeding,” Timothy J. Fischer, president and CEO of HemoSonics, said in the release. “What makes the new QStat Cartridge unique is its unparalleled ease of use and its innovative coagulation tests for critical injury and liver transplant, including platelet contribution to clot

Source link